...
首页> 外文期刊>Brain research >Kappa opioid receptor agonists inhibit sigma-1 (sigma 1) receptor binding in guinea-pig brain, liver and spleen: autoradiographical evidence.
【24h】

Kappa opioid receptor agonists inhibit sigma-1 (sigma 1) receptor binding in guinea-pig brain, liver and spleen: autoradiographical evidence.

机译:κ阿片受体激动剂抑制豚鼠脑,肝和脾中的sigma-1(sigma 1)受体结合:放射自显影证据。

获取原文
获取原文并翻译 | 示例
           

摘要

The present study examined whether the kappa-opioid agonists U50,488H (trans-(+/-)-3,4-dichloro-N-methyl-N[-2-(1-pyrrolidinyl)- cyclohexyl]-benzeacetamide methane sulphonate), bremazocine, spiradoline and ICI 197067 bind to sigma sites in guinea-pig tissues using in vitro, semi-quantitative receptor autoradiography and receptor binding, and compared the binding profile so obtained with those for several selective sigma ligands. Guinea-pigs were killed and their brians, livers and spleens were removed, tissue sections cut and processed for sigma binding site autoradiography using (+)-[3H]-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine ((+)-[3H]-3-PPP), or tissue was wiped and determined by liquid scintillation. Serial slide-mounted sections were incubated with 9-10 concentrations (1 nM-10 microM) of kappa opioids and their potency to inhibit (+)-[3H]-3-PPP binding compared with that of the sigma ligands haloperidol, DTG (1,3 di(o)-tolylguanidine), (+)-3-PPP, (+) and (-)pentazocine, SR 31742A and rimcazole (n = 3, duplicate determinations). Binding of (+)-[3H]-3-PPP to untreated, matched serial tissue sections was used as control. Kd values were estimated in brain, liver and spleen using quantitative, saturation binding analysis, IC50 values were determined from the binding data obtained by slide wiping experiments for each drug, and Ki values were calculated using the Cheng-Prussoff equation. All four kappa opioids inhibited (+)-[3H]-3-PPP binding to sigma 1-receptors with order of potency: brain: U50,488H = spiradoline > bremazocine > ICI 197067; liver: spiradoline > U50,488H > ICI 197067 > bremazocine; spleen: U50,488H > spiradoline > ICI 197067 > bremazocine. By comparison, the sigma ligands inhibited (+)-[3H]-3-PPP binding to matched, serial slide-mounted brain tissue sections (similar results in liver and spleen) with order of potency: SR 31742A > haloperidol > (+)pentazocine > (+)-3-PPP > DTG > (-)pentazocine > rimcazole. (+)-[3H]-3-PPP autoradiography confirmed these binding data. It is concluded that the kappa opioids tested moderately inhibit (+)-[3H]-3-PPP binding to sigma 1-receptors in guinea-pig brain, liver and spleen tissue with Ki values comparable to some selective sigma ligands and therefore are not opioid selective.
机译:本研究检查了κ阿片类激动剂U50,488H(反式(+/-)-3,4-二氯-N-甲基-N [-2-(1-吡咯烷基)-环己基]-苯乙酰胺甲烷磺酸盐)使用体外,半定量受体放射自显影和受体结合,将bremazocine,spiradoline和ICI 197067结合到豚鼠组织中的sigma部位,并将如此获得的结合特性与几种选择性sigma配体的结合特性进行比较。杀死豚鼠并去除其贿赂,肝脏和脾脏,切割组织切片,并使用(+)-[3H] -3-(3-羟苯基)-N-(1-丙基)哌啶进行sigma结合位点放射自显影((+)-[3H] -3-PPP),或擦拭组织并通过液体闪烁测定。将连续的载玻片固定切片与9-10浓度(1 nM-10 microM)的κ阿片样物质温育,与西格玛配体氟哌啶醇DTG相比,它们抑制(+)-[3H] -3-PPP结合的效力( 1,3二(邻)-甲苯基胍),(+)-3-PPP,(+)和(-)戊唑嗪,SR 31742A和rimcazole(n = 3,重复测定)。 (+)-[3H] -3-PPP与未处理的,匹配的连续组织切片的结合用作对照。使用定量的饱和结合分析法估算脑,肝和脾中的Kd值,根据每种药物的载玻片擦拭实验获得的结合数据确定IC50值,并使用Cheng-Prussoff方程计算Ki值。所有四种κ阿片样物质均以有力的顺序抑制(+)-[3H] -3-PPP与σ1受体的结合:脑:U50,488H =螺环索>溴代咪唑啉> ICI 197067;肝脏:螺环素> U50,488H> ICI 197067>溴咪唑;脾脏:U50,488H>螺环索林> ICI 197067>溴咪唑新。相比之下,sigma配体以有力的顺序抑制(+)-[3H] -3-PPP与匹配的,连续的载玻片固定的脑组织切片(在肝和脾中的结果相似)的结合:SR 31742A>氟哌啶醇>(+) pentazocine>(+)-3-PPP> DTG>(-)pentazocine> rimcazole。 (+)-[3H] -3-PPP放射自显影证实了这些结合数据。结论是,在豚鼠的大脑,肝脏和脾脏组织中,所测试的κ阿片类药物可适度抑制(+)-[3H] -3-PPP与σ1受体的结合,其Ki值可与某些选择性σ配体相当。阿片类药物选择性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号